lobbying_activities: 1875268

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1875268	2e0f69b8-e63f-4f07-960c-8191b0916d1b	Q3	WILLIAMS AND JENSEN, PLLC	41454	ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP)	2016	third_quarter	MMM	Medicare prescription drug benefit; Drug rebates for Medicare Part D; Part D benefit structure; Payment policies for Medicare Part B Prescription drugs; Independent Payment Advisory Board (IPAB), repeal of Part D Non-interference Provision; CCMI Medicare Part B Demonstration.	HOUSE OF REPRESENTATIVES,Office of the Vice President of the United States,SENATE	50000		0	0	2016-10-12T10:23:13.777000-04:00